Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in Taiwan.
Bo-Fang ChenYi-Fang TsaiPei-Ju LienYen-Shu LinChin-Jung FengYen-Jen ChenHan-Fang ChengChun-Yu LiuTa-Chung ChaoJiun-I LaiLing-Ming TsengChi-Cheng HuangPublished in: Breast cancer (Tokyo, Japan) (2023)
PIK3CA, FGFR1, and BRCA1/2 were the most prevalent actionable alterations among Taiwanese luminal B1 breast cancer. Moreover, PTEN and BRCA1/2 was significantly associated with disease relapse.